Xiaodong Zheng Selected Research

Paraffin

1/2021	Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors.
7/2014	Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodong Zheng Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 05/2005
18	Hypoxia (Hypoxemia) 06/2022 - 02/2009
16	Obesity 06/2022 - 01/2013
16	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 01/2014
13	Inflammation (Inflammations) 02/2022 - 01/2016
11	Insulin Resistance 06/2022 - 01/2013
10	Body Weight (Weight, Body) 03/2022 - 01/2013
10	Infections 12/2021 - 02/2009
8	Pulmonary Arterial Hypertension 03/2021 - 01/2010
6	Pulmonary Hypertension 01/2022 - 07/2015
6	Fatty Liver 10/2021 - 07/2016
6	Mitochondrial Diseases (Mitochondrial Disease) 09/2021 - 12/2017
6	Wounds and Injuries (Trauma) 11/2019 - 02/2008
5	Hypertension (High Blood Pressure) 01/2022 - 01/2014
5	Mycoses (Diseases, Fungus) 09/2021 - 09/2014
5	Keratitis 09/2014 - 01/2004
4	Lung Neoplasms (Lung Cancer) 09/2021 - 07/2014
4	Hypertrophy 01/2020 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019 - 11/2013
4	Dry Eye Syndromes (Dry Eye Syndrome) 11/2016 - 01/2004
3	Hyperglycemia 11/2021 - 08/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2020 - 10/2016
3	Exfoliation Syndrome 11/2013 - 01/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2014
2	Blepharoptosis (Ptosis, Eyelid) 01/2022 - 10/2016
2	Erythema 01/2022 - 01/2018
2	Hyperlipidemias (Hyperlipidemia) 10/2021 - 10/2018
2	Adenocarcinoma of Lung 09/2021 - 11/2020
2	Leukemia 01/2021 - 09/2015
2	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 07/2014
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2012
2	Disease Resistance 09/2019 - 11/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 03/2018
2	Non-alcoholic Fatty Liver Disease 01/2019 - 10/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
16	Anthocyanins (Anthocyanin)IBA 06/2022 - 01/2013
9	CytokinesIBA 11/2020 - 05/2005
8	Biological ProductsIBA 05/2022 - 05/2014
7	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
7	AntioxidantsIBA 11/2021 - 11/2014
7	LigandsIBA 01/2021 - 03/2014
6	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2020
5	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021 - 11/2014
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2019 - 07/2014
5	Insulin (Novolin)FDA Link 01/2019 - 01/2013
5	LipidsIBA 01/2019 - 01/2013
4	16S Ribosomal RNAIBA 06/2022 - 01/2021
4	Triglycerides (Triacylglycerol)IBA 03/2022 - 10/2016
4	CholesterolIBA 03/2022 - 01/2013
4	CalciumIBA 11/2021 - 09/2010
4	flavoneIBA 11/2021 - 11/2020
4	FlavonoidsIBA 09/2021 - 01/2019
4	LeptinIBA 10/2016 - 01/2013
3	Peptides (Polypeptides)IBA 06/2022 - 06/2012
3	Long Noncoding RNAIBA 01/2022 - 01/2019
3	Caspase 3 (Caspase-3)IBA 01/2022 - 11/2019
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022 - 07/2015
3	EnzymesIBA 09/2021 - 07/2017
3	Circular RNAIBA 03/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 05/2020 - 05/2005
3	Angiotensin IIIBA 01/2020 - 01/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2017 - 01/2016
3	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 09/2010 - 02/2009
2	IronIBA 09/2022 - 09/2021
2	HLA-DRB1 Chains (HLA DRB1)IBA 06/2022 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 05/2022 - 10/2016
2	UbiquitinIBA 01/2022 - 10/2018
2	Caspase 9IBA 01/2022 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2018
2	InflammasomesIBA 12/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 11/2021 - 10/2015
2	kaempferol-3-O-rutinosideIBA 10/2021 - 09/2021
2	Therapeutic UsesIBA 10/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2015
2	ParaffinIBA 01/2021 - 07/2014
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2020
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2018
2	Polysaccharides (Glycans)IBA 02/2020 - 12/2019
2	MonocrotalineIBA 11/2019 - 10/2016
2	Bromodeoxyuridine (BrdU)IBA 11/2019 - 07/2015
2	Cyclophilin AIBA 03/2019 - 01/2017
2	AntibodiesIBA 01/2019 - 09/2015
2	HLA-C Antigens (HLA-C)IBA 01/2019 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2016
2	ChitinIBA 11/2018 - 02/2008
2	Hydroxyeicosatetraenoic Acids (HETE)IBA 10/2018 - 01/2018
2	ovalbumin-alumIBA 01/2018 - 01/2018
2	TubulinIBA 01/2018 - 07/2015
2	OvalbuminIBA 01/2018 - 01/2018

Therapy/Procedure

13	Therapeutics 11/2021 - 11/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2015
3	Radiotherapy 04/2020 - 12/2015
2	Hysterectomy 11/2021 - 05/2020
2	Immunotherapy 01/2021 - 09/2015